Search Protocols under revision. Back New search Go to resultsDiseaseMain groupPediatric Oncology and HematologyProtocol groupBrain Tumors (ped.)DiseaseNeuroblastomaSubgroupAge < 1 yearWeight < 10 kgICD10C47.-MeSHNeuroblastomaSequenceAntineoplastic therapySubstanceCisplatinEtoposide phosphateVindesineSubstanceCisplatinEtoposide phosphateVindesineSubstanceCisplatinEtoposide phosphateVindesineSubstanceCisplatinEtoposide phosphateVindesineNo. Substances3 RadiotherapySupportive therapySubstanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleMagnesium sulfateMannitol 20%Potassium chlorideSubstanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleMagnesium sulfateMannitol 20%Potassium chlorideSubstanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleMagnesium sulfateMannitol 20%Potassium chlorideSubstanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneFilgrastimFosaprepitantGranisetronItraconazoleMagnesium sulfateMannitol 20%Potassium chlorideNo. Substances10Protocol classificationTherapy classificationStudy protocol, currentIntensityStandard doseTherapy indicationFirst lineTherapy phaseTherapy intentioncurativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorCaron HNDiseaseNeuroblastom, Kinder unter 1 Jahr oder unter 10 kgOriginDCOG NBL 2009Protocols in Revision 1 protocol foundPAED Cisplatin 1.3 / Etoposide Phosphate 4.2 / Vindesin 0.1, Neuroblastoma, N5 (PID2876 V1.1)
